[Retracted] Nomogram-Based Prediction of Overall and Cancer-Specific Survival in Patients with Primary Bone Diffuse Large B-Cell Lymphoma: A Population-Based Study

<div>Nomograms predicting three- and five-year OS and CSS in patients with PB-DLBCL. OS = overall survival; CSS = cancer-specific survival; PB-DLBCL = primary bone diffuse large B-cell lymphoma.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: [Retracted] Nomogram-Based Prediction of Overall and Cancer-Specific Survival in Patients with Primary Bone Diffuse Large B-Cell Lymphoma: A Population-Based Study 

Figure 2 | [Retracted] Nomogram-Based Prediction of Overall and Cancer-Specific Survival in Patients with Primary Bone Diffuse Large B-Cell Lymphoma: A Population-Based Study 